cannabigerol: Clinical Trials

2 trials of cannabigerol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 31Terminated 1

Follow cannabigerol: new trials by email Literature Review of cannabigerol trials Research Report on cannabigerol

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
Cannabigerol, Placebo - Attention-Deficit/Hyperactivity Disorder
Phase 2CompletedUniversity of Arkansas, Fayetteville672024-12-142026-11-09
Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine -
Placebo oral drops, Cannabidiol + Cannabigerol + Tetrahydrocannabinol 133/66/4mg - Chronic Migraine, Headache, Overuse Headache Medication
Phase 2 / Phase 3TerminatedHospital Israelita Albert Einstein1102022-10-182025-02-24

Conditions studied

Attention Deficit Disorder with Hyperactivity (1)  ·  Headache (1)  ·  Headache Disorders, Secondary (1)

Sponsors

Hospital Israelita Albert Einstein (1)  ·  University of Arkansas, Fayetteville (1)

Countries

Brazil (1)  ·  United States (1)

Top investigators

Alexandre O Kaup, MD, PhD (1)  ·  Ellen W Leen-Feldner, PhD (1)